ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 84 filers reported holding ORIC PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 2.93 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $294,635 | -63.9% | 48,700 | -53.7% | 0.01% | -65.0% |
Q2 2023 | $816,352 | +36.1% | 105,200 | 0.0% | 0.02% | +25.0% |
Q1 2023 | $599,640 | -3.2% | 105,200 | 0.0% | 0.02% | 0.0% |
Q4 2022 | $619,628 | +199.3% | 105,200 | +62.6% | 0.02% | +166.7% |
Q3 2022 | $207,000 | – | 64,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,007,576 | $25,199,000 | 12.12% |
Svennilson Peter | 4,768,181 | $119,252,000 | 9.73% |
EcoR1 Capital, LLC | 2,642,218 | $66,082,000 | 4.71% |
Orbimed Advisors | 2,921,967 | $73,078,000 | 0.92% |
EMERALD MUTUAL FUND ADVISERS TRUST | 312,483 | $7,815,000 | 0.35% |
EMERALD ADVISERS, LLC | 324,582 | $8,118,000 | 0.33% |
Casdin Capital, LLC | 251,515 | $6,290,000 | 0.28% |
ArrowMark Colorado Holdings LLC | 995,382 | $24,895,000 | 0.24% |
Artal Group S.A. | 142,500 | $3,564,000 | 0.09% |
Alyeska Investment Group, L.P. | 161,585 | $4,041,000 | 0.06% |